Bafna Pharma Board Meeting on Aug 11 to Approve Q1 FY27 Un-Audited Results

Bafna Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item for this meeting is to consider and approve the Un-Audited Financial Results for the first quarter ended June 30, 2026. In line with SEBI regulations and the company's insider trading code, the trading window for designated persons and their immediate relatives will remain closed from July 1, 2026, to August 13, 2026, inclusive, to prevent potential misuse of information related to the financial results.